Cytarabine
Product manufactured by Fresenius Kabi Usa, Llc
Indications and Purposes
| Indications And Usage: Cytarabine Injection In Combination With Other Approved Anti-Cancer Drugs Is Indicated For Remission Induction In Acute Non-Lymphocytic Leukemia Of Adults And Pediatric Patients. It Has Also Been Found Useful In The Treatment Of Acute Non-Lymphocytic Leukemia And The Blast Phase Of Chronic Myelocytic Leukemia. Intrathecal Administration Of Cytarabine Injection (Preservative Free Preparations Only) Is Indicated In The Prophylaxis And Treatment Of Meningeal Leukemia. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Cytarabine |
|
ZINC3795098 |